Disease Overview：Huntington's disease（HD）
Huntington’s disease (HD) is an autosomal dominant, progressive neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the HTT gene, leading to mutant huntingtin protein accumulation. It typically manifests in mid-adulthood with a triad of motor dysfunction—including chorea, dystonia, and impaired gait—cognitive decline characterized by executive dysfunction and slowed processing speed—and psychiatric symptoms such as depression, apathy, and irritability. Diagnosis relies on clinical evaluation, genetic testing for HTT expansion (>36 repeats), and supportive neuroimaging showing caudate atrophy and cortical thinning on MRI. While no disease-modifying therapy currently exists, comprehensive management focuses on symptom control: tetrabenazine or deutetrabenazine for chorea; SSRIs or antipsychotics for behavioral manifestations; and multidisciplinary rehabilitation involving neurology, psychiatry, speech-language pathology, and physical therapy. Prognosis remains guarded, with median survival 15–20 years post-onset.
China offers distinct advantages for HD care: leading neurology centers—such as Beijing Tiantan Hospital and Shanghai Huashan Hospital—host specialized movement disorders units with deep expertise in HD phenotyping, genetic counseling, and longitudinal symptom management. Advanced neuroimaging (7T MRI, quantitative volumetric analysis), pharmacogenomic profiling, and access to emerging therapies in clinical trials enhance precision. Real-world outcomes reflect high adherence to international guidelines and robust palliative integration. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising quality—e.g., a full-year multidisciplinary care package including genetic testing, MRI, medication, and rehab averages USD $8,500–$12,000 versus $25,000+ overseas. As a dedicated medical tourism agency, we facilitate seamless international patient journeys: vetting accredited hospitals, coordinating appointments with HD-specialized neurologists, providing transparent, all-inclusive pricing, and delivering end-to-end support—from visa assistance and medical translation to accommodation and follow-up coordination.
Huntington's disease: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Huntington’s Disease (Neurology Department)
Non-Surgical / Conservative Management
*Target Criteria:* Confirmed genetic diagnosis (CAG ≥40), early–moderate motor/cognitive/psychiatric symptoms; no contraindications to pharmacotherapy.
- •Symptomatic Pharmacotherapy
- *Psychosis/agitation:* Quetiapine (200–400 mg/day): ¥120–¥200/month (
$17–$29) - *Depression/anxiety:* Sertraline (50–150 mg/day): ¥60–¥100/month ($9–$14)- •
- Routine labs (CBC, LFTs, renal panel): ¥180 (
$26) - Annual brain MRI (1.5T, axial T2/FLAIR + DWI): ¥720 ($103)- •
- Clinical psychology counseling (45-min): ¥220 (
$32) - Speech-language therapy (45-min): ¥240 ($34)Surgical / Procedural Interventions
*Eligibility Criteria:* Refractory chorea unresponsive to ≥6 months of maximal-dose tetrabenazine/deutetrabenazine; preserved cognition (MMSE ≥24); no structural brain contraindications; confirmed CAG expansion.
- •
- Bilateral GPi DBS implantation (incl. frameless stereotaxy, intraoperative microelectrode recording, pulse generator): ¥215,000–¥268,000 (
$30,900–$38,500) - Post-op programming (3 sessions over 6 months): ¥2,400 ($345)- •
Special / Complex Condition Management
- •
Quick Selection Guide
- •
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Huntington's disease Medical Vacation Packages
Curated transparent all-inclusive packages combining Huntington's disease treatment with China top medical destinations:
